OPINION: Drug Makers’ Advantage - New York Times

OPINION: Drug Makers’ Advantage - New York Times: "Like the doctrine of pre-emptive war that led to Iraq, F.D.A. pre-emption is a policy concocted in oblivion, an ideology without connection to the ways the agency and industry actually work. The editors of The New England Journal of Medicine recently wrote that that policy would have cataclysmic consequences for patients’ rights, industry accountability and public health. It is not often that doctors defend trial lawyers. Having now heard what the most respected voice in American medicine has to say, we should have no illusions where we are headed."